RALEIGH, N.C.--(BUSINESS WIRE)--Merz Neuroscience, a division of Merz North America, today announced that Kevin O’Brien will join as the Vice President and U.S. Head of Neurosciences, effective immediately. Mr. O’Brien will relocate to the Merz North America headquarters in Raleigh, N.C.
“We are honored to have Kevin join Merz with his proven track record of success leading sales and marketing teams globally and his extensive industry knowledge. He is highly collaborative and will be a strong and strategic addition to our leadership team,” commented Bob Rhatigan, President and CEO of Merz North America. “We are deeply committed to the neurotoxins field and ultimately to helping patients who suffer from movement disorders.”
In his new role, Mr. O'Brien will assume responsibility for the U.S. neuroscience business including oversight of field sales, managed markets and marketing. He will also join the North America Leadership Team (NALT).
“I am honored and excited to lead the dynamic Merz U.S. neurosciences team in order to grow our position in the market and reach patients who are in need of innovative treatments,” said Mr. O’Brien. “Merz is globally recognized for its work in neurology. I plan to build upon the team’s legacy of innovation to help ensure that patients and their health care providers have access to Merz’s meaningful treatment options.”
Prior to joining Merz, Mr. O’Brien spent the last 16 years working for Allergan in the dermatology and aesthetics business. He is a global healthcare executive with over 25 years of experience in sales, leadership and business development in the United States, Canada and Asia Pacific. He has broad exposure in building and leading teams and product launches in medical aesthetics, plastic surgery, dermatology and injectables. Mr. O’Brien has held various positions at Allergan and outside of Allergan including J&J and Boston Scientific in both sales and marketing functions.
Merz North America is a significant contributor to the company’s global business in both aesthetics and neurotoxins as the two areas of global strategic focus.
To learn more, visit www.merzusa.com.
About Merz Neurosciences
Merz Neurosciences is a division of Merz North America and is deeply committed to offering novel therapeutic options that address the largely unmet medical needs that exist within the area of neuroscience. Merz Neurosciences is an important contributor to the U.S. neurosciences space and offers a portfolio that includes the neurotoxin Xeomin® (incobotulinumtoxinA), the anticholinergic Cuvposa® (glycopyrrolate) Oral Solution and the Prolaryn® injectable implant family of products. To learn more about Merz Neurosciences and their U.S. product portfolio, please visit www.merzusa.com/neurosciences.
About Merz North America
Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the United States and Canada. Merz products are distributed through two divisions, Aesthetics and Neurosciences, and are developed with the goal of improving patients’ health and quality of life by delivering therapies that bring about real progress. Merz North America is a privately-held company based in Raleigh, North Carolina. To learn more about Merz North America, please visit www.merzusa.com.
